Cargando…

Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of Pasteurella multocida in a Murine Lung Infection Model

Gamithromycin is approved for the treatment and prevention of bovine respiratory disease (BRD), which is caused mainly by Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma species. In this study, multiple dosage regimens were administered to the neutropenic mouse lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qingwen, Liu, Xuesong, Zhang, Chenghuan, Yong, Kang, Clifton, Alancia Carol, Ding, Huanzhong, Liu, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798029/ https://www.ncbi.nlm.nih.gov/pubmed/31680940 http://dx.doi.org/10.3389/fphar.2019.01090

Ejemplares similares

Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model
por: Zhou, Qiaoyi, et al.
Publicado: (2017)

Increased Antimicrobial Activity of Colistin in Combination With Gamithromycin Against Pasteurella multocida in a Neutropenic Murine Lung Infection Model
por: Li, Yanqin, et al.
Publicado: (2020)

Pharmacokinetic/pharmacodynamic integration of tilmicosin against Pasteurella multocida in a piglet tissue cage model
por: Chen, Yuqin, et al.
Publicado: (2023)

Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model
por: Qu, Ying, et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model
por: Zeng, Dongping, et al.
Publicado: (2018)

Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling
por: Lee, Eon-Bee, et al.
Publicado: (2023)

The pharmacokinetics and pharmacodynamics of cefquinome against Streptococcus agalactiae in a murine mastitis model
por: Yang, Qingwen, et al.
Publicado: (2023)

Optimal Regimens and Cutoff Evaluation of Tildipirosin Against Pasteurella multocida
por: Lei, Zhixin, et al.
Publicado: (2018)

Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida
por: Dorey, L., et al.
Publicado: (2017)

Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida
por: Dorey, Lucy, et al.
Publicado: (2017)

Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling
por: Dorey, Lucy, et al.
Publicado: (2017)

Optimization and Validation of Dosage Regimen for Ceftiofur against Pasteurella multocida in Swine by Physiological Based Pharmacokinetic–Pharmacodynamic Model
por: Mi, Kun, et al.
Publicado: (2022)

Transcriptomic Analysis on Responses of Murine Lungs to Pasteurella multocida Infection
por: Wu, Chenlu, et al.
Publicado: (2017)

In vivo Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against Pasteurella multocida in Ducks
por: Xiao, Xia, et al.
Publicado: (2021)

Pasteurella multocida Epiglottitis
por: Moyko, Andrey, et al.
Publicado: (2017)

Development of an Online Tool for Pasteurella multocida Genotyping and Genotypes of Pasteurella multocida From Different Hosts
por: Peng, Zhong, et al.
Publicado: (2021)

Integrated pharmacokinetic–Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets
por: Zeng, Qing Lin, et al.
Publicado: (2017)

Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against Mycoplasma hyopneumoniae in an In Vitro Model
por: Zhang, Huilin, et al.
Publicado: (2019)

Infective Exacerbation of Pasteurella multocida
por: Hamada, Mayumi, et al.
Publicado: (2016)

Infantile Pasteurella multocida meningitis
por: Nauseef, Jones T., et al.
Publicado: (2016)

Endocarditis caused by Pasteurella multocida
por: Al Ghonaim, Mohammed A., et al.
Publicado: (2006)

Pasteurella Multocida Infection in Humans
por: Piorunek, Marcin, et al.
Publicado: (2023)

Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling
por: Liu, Xuesong, et al.
Publicado: (2021)

Role of aspartate ammonia-lyase in Pasteurella multocida
por: Wang, Zui, et al.
Publicado: (2020)

Identification of novel immunogens in Pasteurella multocida
por: Al-Hasani, Keith, et al.
Publicado: (2007)

Pasteurella multocida Bacteremia in an Immunocompromised Patient
por: Kukrety, Shweta, et al.
Publicado: (2016)

Bronchopneumonia Due to Pasteurella Multocida (Septica)
por: Hayes, J. A., et al.
Publicado: (1961)

The Myriad Properties of Pasteurella multocida Lipopolysaccharide
por: Harper, Marina, et al.
Publicado: (2017)

Pasteurella multocida prosthetic joint infection
por: Runnstrom, Martin, et al.
Publicado: (2018)

In Vivo Targets of Pasteurella Multocida Toxin
por: Banu, Arshiya, et al.
Publicado: (2020)

Pharmacodynamic Target Assessment and PK/PD Cutoff Determination for Gamithromycin Against Streptococcus suis in Piglets
por: Wang, Rui-Ling, et al.
Publicado: (2022)

Pharmacokinetic and Pharmacodynamic Integration and Resistance Analysis of Tilmicosin Against Mycoplasma gallisepticum in an In Vitro Dynamic Model
por: Huang, Zilong, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae
por: Li, Xin, et al.
Publicado: (2021)

Gamithromycin in swine: Pharmacokinetics and clinical evaluation against swine respiratory disease
por: Hamel, Dietmar, et al.
Publicado: (2020)

Hydrogen Peroxide as an Effective Disinfectant for Pasteurella multocida
por: Jung, In-Soo, et al.
Publicado: (2014)

Biofilm formation of Pasteurella multocida on bentonite clay
por: Rajagopal, Ramachandranpillai, et al.
Publicado: (2013)

The actions of Pasteurella multocida toxin on neuronal cells()
por: Surguy, Susan M., et al.
Publicado: (2014)

Vascular graft infection due to Pasteurella multocida
por: Fourreau, F., et al.
Publicado: (2015)

Clinical Features and Outcomes of Pasteurella multocida Infection
por: Giordano, Antonio, et al.
Publicado: (2015)

Pasteurella multocida Toxin Manipulates T Cell Differentiation
por: Hildebrand, Dagmar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7uhlr8r36o33b50aj1c9pfchr8